348 — China Healthwise Holdings Income Statement
0.000.00%
Last trade - 00:00- HK$73.97m
- HK$132.99m
- HK$113.58m
Annual income statement for China Healthwise Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 138 | 170 | 142 | 146 | 114 |
| Cost of Revenue | |||||
| Gross Profit | 61.1 | 91 | 53.3 | 60.3 | 37.3 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 192 | 162 | 191 | 269 | 145 |
| Operating Profit | -54.1 | 8.44 | -49.1 | -123 | -31.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -72.9 | -101 | -56.4 | -132 | -40 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -69.3 | -103 | -54.3 | -135 | -40.3 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -25.2 | -103 | -54.3 | -135 | -40.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -25.2 | -103 | -54.3 | -135 | -40.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.045 | -0.131 | -0.053 | -0.084 | -0.044 |